Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma

被引：31

作者：

Ohmura, Shunya ^{[1
,2
,3
,4
]}

Marchetto, Aruna ^{[4
]}

Orth, Martin F. ^{[4
]}

Li, Jing ^{[1
,2
,3
]}

Jabar, Susanne ^{[5
,6
]}

Ranft, Andreas ^{[5
,6
]}

Vinca, Endrit ^{[1
,2
,3
]}

Ceranski, Katharina ^{[1
,2
,3
]}

Carreno-Gonzalez, Martha J. ^{[1
,2
,3
]}

Romero-Perez, Laura ^{[1
,2
,3
,4
]}

Wehweck, Fabienne S. ^{[4
]}

Musa, Julian ^{[1
,2
,3
,4
,7
]}

Bestvater, Felix ^{[8
]}

Knott, Maximilian M. L. ^{[4
]}

Hoelting, Tilman L. B. ^{[4
]}

Hartmann, Wolfgang ^{[9
]}

Dirksen, Uta ^{[5
,6
]}

Kirchner, Thomas ^{[10
,11
]}

Cidre-Aranaz, Florencia ^{[1
,2
,3
,4
]}

Grunewald, Thomas G. P. ^{[1
,2
,3
,4
,12
]}

机构：

[1] Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany

[2] German Canc Res Ctr, Div Translat Pediat Sarcoma Res B410, Neuenheimer Feld 280, D-69210 Heidelberg, Germany

[3] Hopp Childrens Canc Ctr KiTZ, Neuenheimer Feld 280, D-69210 Heidelberg, Germany

[4] Ludwig Maximilians Univ Munchen, Inst Pathol, Fac Med, Max Eder Res Grp Pediat Sarcoma Biol, Munich, Germany

[5] Univ Hosp Essen, West German Canc Ctr, Pediat 3, Essen, Germany

[6] German Canc Consortium DKTK, Partner Site Essen, Essen, Germany

[7] Heidelberg Univ Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany

[8] German Canc Consortium DKTK, Light Microscopy Facil, German Canc Res Ctr DKFZ, Heidelberg, Germany

[9] Univ Hosp Munster, Gerhard Domagk Inst Pathol, Div Translat Pathol, Munster, Germany

[10] Ludwig Maximilians Univ Munchen, Inst Pathol, Fac Med, Munich, Germany

[11] German Canc Consortium DKTK, Partner Site Munich, Munich, Germany

[12] Heidelberg Univ Hosp, Inst Pathol, Heidelberg, Germany

来源：

MOLECULAR CANCER | 2021年 / 20卷 / 01期

关键词：

Ewing sarcoma; RRM2; Targeted therapy; Prognostic biomarker; Paediatric oncology; Triapine; Chemoresistance; RIBONUCLEOTIDE REDUCTASE INHIBITOR; GTI-2040 PLUS DOCETAXEL; 3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE; PHASE-I/II; MANAGEMENT; RECURRENCE;

D O I：

10.1186/s12943-021-01393-9

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页数：7

共 21 条

[1] Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies [J].

Aye, Y. ;

Li, M. ;

Long, M. J. C. ;

Weiss, R. S. .

ONCOGENE, 2015, 34 (16) :2011-2021

[2] In vitro and in vivo radiosensitization induced by the ribonucleotide reductase inhibitor-triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone) [J].

Barker, CA ;

Burgan, WE ;

Carter, DJ ;

Cerna, D ;

Gius, D ;

Hollingshead, MG ;

Camphausen, K ;

Tofilon, PJ .

CLINICAL CANCER RESEARCH, 2006, 12 (09) :2912-2918

[3] A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study [J].

Chao, Joseph ;

Synold, Timothy W. ;

Morgan, Robert J., Jr. ;

Kunos, Charles ;

Longmate, Jeff ;

Lenz, Heinz-Josef ;

Lim, Dean ;

Shibata, Stephen ;

Chung, Vincent ;

Stoller, Ronald G. ;

Belani, Chandra P. ;

Gandara, David R. ;

McNamara, Mark ;

Gitlitz, Barbara J. ;

Lau, Derick H. ;

Ramalingam, Suresh S. ;

Davies, Angela ;

Espinoza-Delgado, Igor ;

Newman, Edward M. ;

Yen, Yun .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) :835-843

[4] Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma [J].

Dai, L. ;

Lin, Z. ;

Qiao, J. ;

Chen, Y. ;

Flemington, E. K. ;

Qin, Z. .

ONCOGENE, 2017, 36 (35) :5068-5074

[5] Triapine (3-aminopyridine-2-carboxaldehydethiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity [J].

Finch, RA ;

Liu, MC ;

Grill, SP ;

Rose, WC ;

Loomis, R ;

Vasquez, KM ;

Cheng, YC ;

Sartorelli, AC .

BIOCHEMICAL PHARMACOLOGY, 2000, 59 (08) :983-991

[6] Ewing Sarcoma: Current Management and Future Approaches Through Collaboration [J].

Gaspar, Nathalie ;

Hawkins, Douglas S. ;

Dirksen, Uta ;

Lewis, Ian J. ;

Ferrari, Stefano ;

Le Deley, Marie-Cecile ;

Kovar, Heinrich ;

Grimer, Robert ;

Whelan, Jeremy ;

Claude, Line ;

Delattre, Olivier ;

Paulussen, Michael ;

Picci, Piero ;

Hall, Kirsten Sundby ;

van den Berg, Hendrik ;

Ladenstein, Ruth ;

Michon, Jean ;

Hjorth, Lars ;

Judson, Ian ;

Luksch, Roberto ;

Bernstein, Mark L. ;

Marec-Berard, Perrine ;

Brennan, Bernadette ;

Craft, Alan W. ;

Womer, Richard B. ;

Juergens, Heribert ;

Oberlin, Odile .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (27) :3036-U140

[7] Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine [J].

Goss, Kelli L. ;

Koppenhafer, Stacia L. ;

Harmoney, Kathryn M. ;

Terry, William W. ;

Gordon, David J. .

ONCOTARGET, 2017, 8 (50) :87016-87032

[8] Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma [J].

Goss, Kelli L. ;

Gordon, David J. .

ONCOTARGET, 2016, 7 (39) :63003-63019

[9] Ewing sarcoma [J].

Gruenewald, Thomas G. P. ;

Cidre-Aranaz, Florencia ;

Surdez, Didier ;

Tomazou, Eleni M. ;

de Alava, Enrique ;

Kovar, Heinrich ;

Sorensen, Poul H. ;

Delattre, Olivier ;

Dirksen, Uta .

NATURE REVIEWS DISEASE PRIMERS, 2018, 4

[10]

Kunos CA, 2012, FUTURE ONCOL, V8, P145, DOI [10.2217/fon.11.147, 10.2217/FON.11.147]

← 1 2 3 →